24927123 16765945 17516572 26464852 19642171 20360931 31120172 16915295 33617094 19645015 16951235 35754740 17243941 19194591 17409420 21182488 19199366 19228731 23128395 23599173 27495374 19016759 19764996 19105244 16989597 28962320 18716165 2056414 - Search Results

Year	Number of Results
2006	7
2007	7
2008	6
2009	9
2010	3
2011	1
2012	4
2013	7
2014	5
2016	2
2017	3
2019	2
2020	2
2021	1
2022	2
2023	0

1

Signaling mechanisms that suppress the cytostatic actions of rapamycin.

Jahn SC, Law ME, Corsino PE, Davis BJ, Harrison JK, Law BK. Jahn SC, et al. PLoS One. 2014 Jun 13;9(6):e99927. doi: 10.1371/journal.pone.0099927. eCollection 2014. PLoS One. 2014. PMID: 24927123 Free PMC article.

2

A new inducible RNAi xenograft model for assessing the staged tumor response to mTOR silencing.

Ke N, Zhou D, Chatterton JE, Liu G, Chionis J, Zhang J, Tsugawa L, Lynn R, Yu D, Meyhack B, Wong-Staal F, Li QX. Ke N, et al. Exp Cell Res. 2006 Sep 10;312(15):2726-34. doi: 10.1016/j.yexcr.2006.05.001. Exp Cell Res. 2006. PMID: 16765945

3

Rapamycin inhibits osteoblast proliferation and differentiation in MC3T3-E1 cells and primary mouse bone marrow stromal cells.

Singha UK, Jiang Y, Yu S, Luo M, Lu Y, Zhang J, Xiao G. Singha UK, et al. J Cell Biochem. 2008 Feb 1;103(2):434-46. doi: 10.1002/jcb.21411. J Cell Biochem. 2008. PMID: 17516572

4

p21(WAF1/CIP1) Expression is Differentially Regulated by Metformin and Rapamycin.

Molnar Z, Millward AB, Tse W, Demaine AG. Molnar Z, et al. Int J Chronic Dis. 2014;2014:327640. doi: 10.1155/2014/327640. Epub 2014 Mar 25. Int J Chronic Dis. 2014. PMID: 26464852 Free PMC article.

5

Rapamycin delays tumor development in murine livers by inhibiting proliferation of hepatocytes with DNA damage.

Buitrago-Molina LE, Pothiraju D, Lamlé J, Marhenke S, Kossatz U, Breuhahn K, Manns MP, Malek N, Vogel A. Buitrago-Molina LE, et al. Hepatology. 2009 Aug;50(2):500-9. doi: 10.1002/hep.23014. Hepatology. 2009. PMID: 19642171

6

Biomarker Development for the Clinical Activity of the mTOR Inhibitor Everolimus (RAD001): Processes, Limitations, and Further Proposals.

O'Reilly T, McSheehy PM. O'Reilly T, et al. Transl Oncol. 2010 Apr;3(2):65-79. doi: 10.1593/tlo.09277. Transl Oncol. 2010. PMID: 20360931 Free PMC article.

7

Role of the mTOR signalling pathway in salivary gland development.

Sakai M, Fukumoto M, Ikai K, Ono Minagi H, Inagaki S, Kogo M, Sakai T. Sakai M, et al. FEBS J. 2019 Sep;286(18):3701-3717. doi: 10.1111/febs.14937. Epub 2019 Jun 3. FEBS J. 2019. PMID: 31120172 Free article.

8

mTOR and cancer: insights into a complex relationship.

Sabatini DM. Sabatini DM. Nat Rev Cancer. 2006 Sep;6(9):729-34. doi: 10.1038/nrc1974. Epub 2006 Aug 17. Nat Rev Cancer. 2006. PMID: 16915295 Review.

9

MTOR promotes basal cell carcinoma growth through atypical PKC.

Chow RY, Levee TM, Kaur G, Cedeno DP, Doan LT, Atwood SX. Chow RY, et al. Exp Dermatol. 2021 Mar;30(3):358-366. doi: 10.1111/exd.14255. Epub 2020 Dec 20. Exp Dermatol. 2021. PMID: 33617094

10

Hydrogen peroxide induces G2 cell cycle arrest and inhibits cell proliferation in osteoblasts.

Li M, Zhao L, Liu J, Liu AL, Zeng WS, Luo SQ, Bai XC. Li M, et al. Anat Rec (Hoboken). 2009 Aug;292(8):1107-13. doi: 10.1002/ar.20925. Anat Rec (Hoboken). 2009. PMID: 19645015 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results